SCHEMBL19685697

SCHEMBL19685697

Cc1cc(=O)c2cc(-n3c4ccc(N(c5ccccc5)c5ccccc5)cc4c4cc(N(c5ccccc5)c5ccccc5)ccc43)ccc2o1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.45
CYP1A1 P04798 3/20 0.39
CYP1A2 P05177 3/20 0.39
CYP1B1 Q16678 3/20 0.39
KDM4E B2RXH2 3/20 0.36
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
APP P05067 1/20 0.35
PLA2G2A P14555 1/20 0.33
PLA2G4A P47712 1/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TNKS O95271 1/20 0.33
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685695 0.91 ACHE (0.38) ACHECYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL19685957 0.87 ACHE (0.57) ACHECYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL19685693 0.84 ACHE (0.49) ACHECYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL19685694 0.82 PLA2G2A (0.50) ACHECYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL21587149 0.81 KDM4E (0.39) CYP1A2KDM4EMAPTALDH1A1HPGD
SCHEMBL12158894 0.79 KDM4E (0.38) CYP1A2KDM4EMAPTALDH1A1HPGD
SCHEMBL24398731 0.79 CHRNA7 (0.40) KDM4EMAPTALDH1A1CYP3A4HPGD
SCHEMBL19686136 0.79 ALDH1A1 (0.37) ALDH1A1HSD17B10CA12CA9APP
SCHEMBL18511436 0.79 ACHE (0.41) ACHECYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL21610871 0.78 KDM4E (0.42) CYP1A2KDM4EMAPTALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS ACHE 3408/4885CYP1A1 102/4885CYP1A2 902/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS ACHE 3408/4885CYP1A1 102/4885CYP1A2 902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.